Dr Ken Yeong discusses the future of drugs such as re-purposing them for other medical uses and to look at innovating existing drugs.

He graduated with a PhD specializing in Medicinal Chemistry and has published original research and review papers in the area of drug design and discovery. He has also delivered talks in numerous international conferences and his current research interests include identifying novel molecules to treat age-related diseases, such as cancer and Alzheimer’s via a sirtuin enzyme modulation. Prior to joining Monash University as a lecturer in the School of Science, he has worked as a senior research scientist for a biotechnology company, and later for a multinational diagnostic research corporation.